Tourmaline Bio (NASDAQ:TRML) Shares Down 7.8%

Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) traded down 7.8% during trading on Tuesday . The stock traded as low as $38.61 and last traded at $39.33. 64,967 shares were traded during mid-day trading, a decline of 73% from the average session volume of 238,561 shares. The stock had previously closed at […]

Related Keywords

Leerink Partnrs ,Mark Mcdade ,Piper Sandler ,Nasdaq ,Tourmaline Bio Inc ,Tourmaline Bio Company Profile ,Goldman Sachs Group Inc ,Cubist Systematic Strategies ,Northern Trust Corp ,Dimensional Fund Advisors ,Jump Financial ,Jefferies Financial Group ,Tourmaline Bio ,Get Free Report ,Financial Group ,Director Mark Mcdade ,Sachs Group ,Systematic Strategies ,Fund Advisors ,Tourmaline Bio Daily ,Nasdaq Trml ,Trml ,Medical ,Stocks ,Technicals ,